680 George Street
Level 12
Sydney, NSW 2000
Australia
61 2 8280 7355
https://www.elixinolwellness.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Ronald Dufficy BEC, FCPA | Group CEO, MD & Director | 284.18k | N/A | N/A |
Ms. Josephine Lorenz | Global CFO & Joint Company Secretary | 215.88k | N/A | N/A |
Glen Zurcher | Account Director of Investor Relations Department | N/A | N/A | N/A |
Ms. Sarah Prince ACIS, BA, GrdDipCorpGov, LLB | Joint Company Secretary | N/A | N/A | N/A |
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. Elixinol Wellness Limited was incorporated in 2017 and is headquartered in Sydney, Australia.
Elixinol Wellness Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.